4//SEC Filing
DUNCAN MICHAEL R 4
Accession 0001252998-04-000003
CIK 0000809875other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 6:29 PM ET
Size
14.0 KB
Accession
0001252998-04-000003
Insider Transaction Report
Form 4
DUNCAN MICHAEL R
VP and General Manager
Transactions
- Exercise/Conversion
Stock Option (Right-to-Buy)
2004-08-16$9.63/sh−1,000$9,625→ 1,700 totalExercise: $9.63From: 1997-11-18Exp: 2006-11-18→ Common Stock (1,000 underlying) - Exercise/Conversion
Stock Option (Right-to-Buy)
2004-08-16$9.72/sh−4,000$38,876→ 0 totalExercise: $9.72From: 2001-04-19Exp: 2010-04-19→ Common Stock (4,000 underlying) - Sale
Common Stock, $.001 Par Value
2004-08-16$30.11/sh−1,000$30,110→ 550 total - Exercise/Conversion
Common Stock, $.001 Par Value
2004-08-16$9.72/sh+4,000$38,876→ 4,550 total - Exercise/Conversion
Common Stock, $.001 Par Value
2004-08-16$9.63/sh+1,000$9,625→ 1,550 total - Sale
Common Stock, $.001 Par Value
2004-08-16$30.11/sh−4,000$120,440→ 550 total
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adpoted by the reporting person.
Documents
Issuer
ATRIX LABORATORIES INC
CIK 0000809875
Entity typeother
Related Parties
1- filerCIK 0001252998
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 6:29 PM ET
- Size
- 14.0 KB